vs
Side-by-side financial comparison of Keysight Technologies (KEYS) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
Keysight Technologies is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.3× PERRIGO Co plc). Keysight Technologies runs the higher net margin — 16.4% vs -127.8%, a 144.2% gap on every dollar of revenue. On growth, Keysight Technologies posted the faster year-over-year revenue change (10.3% vs -2.5%). Keysight Technologies produced more free cash flow last quarter ($187.0M vs $148.6M). Over the past eight quarters, Keysight Technologies's revenue compounded faster (6.2% CAGR vs 1.3%).
Keysight Technologies, Inc. is an American company that manufactures electronics test and measurement equipment and software. The company was formed as a spin-off of Agilent Technologies, which inherited and rebranded the test and measurement product lines developed and produced, from the late 1960s to the turn of the millennium, by Hewlett-Packard's Test and Measurement division. Its name is a portmanteau of key and insight.
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
KEYS vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $1.1B |
| Net Profit | $233.0M | $-1.4B |
| Gross Margin | 61.2% | 32.6% |
| Operating Margin | 15.3% | -116.0% |
| Net Margin | 16.4% | -127.8% |
| Revenue YoY | 10.3% | -2.5% |
| Net Profit YoY | 419.2% | -3093.9% |
| EPS (diluted) | $1.35 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $1.4B | $1.0B | ||
| Q2 25 | $1.3B | $1.1B | ||
| Q1 25 | $1.3B | $1.0B | ||
| Q4 24 | $1.3B | $1.1B | ||
| Q3 24 | $1.2B | $1.1B | ||
| Q2 24 | $1.2B | $1.1B | ||
| Q1 24 | $1.3B | $1.1B |
| Q4 25 | $233.0M | $-1.4B | ||
| Q3 25 | $191.0M | $7.5M | ||
| Q2 25 | $257.0M | $-8.4M | ||
| Q1 25 | $169.0M | $-6.4M | ||
| Q4 24 | $-73.0M | $-44.4M | ||
| Q3 24 | $389.0M | $-21.0M | ||
| Q2 24 | $126.0M | $-108.4M | ||
| Q1 24 | $172.0M | $2.0M |
| Q4 25 | 61.2% | 32.6% | ||
| Q3 25 | 61.7% | 36.1% | ||
| Q2 25 | 62.3% | 34.4% | ||
| Q1 25 | 63.2% | 37.6% | ||
| Q4 24 | 62.3% | 33.9% | ||
| Q3 24 | 62.0% | 37.2% | ||
| Q2 24 | 62.7% | 37.0% | ||
| Q1 24 | 64.6% | 33.1% |
| Q4 25 | 15.3% | -116.0% | ||
| Q3 25 | 17.3% | 7.0% | ||
| Q2 25 | 15.8% | 4.3% | ||
| Q1 25 | 16.8% | 4.5% | ||
| Q4 24 | 17.9% | 10.0% | ||
| Q3 24 | 16.8% | 7.4% | ||
| Q2 24 | 14.6% | -2.5% | ||
| Q1 24 | 17.6% | -5.1% |
| Q4 25 | 16.4% | -127.8% | ||
| Q3 25 | 14.1% | 0.7% | ||
| Q2 25 | 19.7% | -0.8% | ||
| Q1 25 | 13.0% | -0.6% | ||
| Q4 24 | -5.7% | -3.9% | ||
| Q3 24 | 32.0% | -1.9% | ||
| Q2 24 | 10.4% | -10.2% | ||
| Q1 24 | 13.7% | 0.2% |
| Q4 25 | $1.35 | $-10.23 | ||
| Q3 25 | $1.10 | $0.05 | ||
| Q2 25 | $1.49 | $-0.06 | ||
| Q1 25 | $0.97 | $-0.05 | ||
| Q4 24 | $-0.41 | $-0.32 | ||
| Q3 24 | $2.22 | $-0.15 | ||
| Q2 24 | $0.72 | $-0.79 | ||
| Q1 24 | $0.98 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9B | — |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $5.9B | $2.9B |
| Total Assets | $11.3B | $8.5B |
| Debt / EquityLower = less leverage | 0.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.9B | — | ||
| Q3 25 | $2.6B | $432.1M | ||
| Q2 25 | $3.1B | $454.2M | ||
| Q1 25 | $2.1B | $409.9M | ||
| Q4 24 | $1.8B | $558.8M | ||
| Q3 24 | $1.6B | $1.5B | ||
| Q2 24 | $1.7B | $542.8M | ||
| Q1 24 | $1.7B | $658.5M |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.5B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $1.8B | — | ||
| Q4 24 | $1.8B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.8B | — |
| Q4 25 | $5.9B | $2.9B | ||
| Q3 25 | $5.7B | $4.4B | ||
| Q2 25 | $5.5B | $4.5B | ||
| Q1 25 | $5.2B | $4.4B | ||
| Q4 24 | $5.1B | $4.3B | ||
| Q3 24 | $5.2B | $4.6B | ||
| Q2 24 | $4.9B | $4.5B | ||
| Q1 24 | $4.8B | $4.7B |
| Q4 25 | $11.3B | $8.5B | ||
| Q3 25 | $10.7B | $10.1B | ||
| Q2 25 | $10.5B | $10.1B | ||
| Q1 25 | $9.4B | $9.8B | ||
| Q4 24 | $9.3B | $9.6B | ||
| Q3 24 | $9.3B | $11.2B | ||
| Q2 24 | $9.0B | $10.4B | ||
| Q1 24 | $9.1B | $10.6B |
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.46× | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 0.35× | — | ||
| Q3 24 | 0.34× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 0.38× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $225.0M | $175.4M |
| Free Cash FlowOCF − Capex | $187.0M | $148.6M |
| FCF MarginFCF / Revenue | 13.2% | 13.4% |
| Capex IntensityCapex / Revenue | 2.7% | 2.4% |
| Cash ConversionOCF / Net Profit | 0.97× | — |
| TTM Free Cash FlowTrailing 4 quarters | $1.3B | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $225.0M | $175.4M | ||
| Q3 25 | $322.0M | $51.7M | ||
| Q2 25 | $484.0M | $75.9M | ||
| Q1 25 | $378.0M | $-64.5M | ||
| Q4 24 | $359.0M | $312.6M | ||
| Q3 24 | $255.0M | $42.2M | ||
| Q2 24 | $110.0M | $9.5M | ||
| Q1 24 | $328.0M | $-1.4M |
| Q4 25 | $187.0M | $148.6M | ||
| Q3 25 | $291.0M | $29.8M | ||
| Q2 25 | $457.0M | $56.7M | ||
| Q1 25 | $346.0M | $-90.0M | ||
| Q4 24 | $321.0M | $274.9M | ||
| Q3 24 | $222.0M | $15.1M | ||
| Q2 24 | $74.0M | $-18.9M | ||
| Q1 24 | $281.0M | $-26.5M |
| Q4 25 | 13.2% | 13.4% | ||
| Q3 25 | 21.5% | 2.9% | ||
| Q2 25 | 35.0% | 5.4% | ||
| Q1 25 | 26.7% | -8.6% | ||
| Q4 24 | 24.9% | 24.2% | ||
| Q3 24 | 18.2% | 1.4% | ||
| Q2 24 | 6.1% | -1.8% | ||
| Q1 24 | 22.3% | -2.4% |
| Q4 25 | 2.7% | 2.4% | ||
| Q3 25 | 2.3% | 2.1% | ||
| Q2 25 | 2.1% | 1.8% | ||
| Q1 25 | 2.5% | 2.4% | ||
| Q4 24 | 3.0% | 3.3% | ||
| Q3 24 | 2.7% | 2.5% | ||
| Q2 24 | 3.0% | 2.7% | ||
| Q1 24 | 3.7% | 2.3% |
| Q4 25 | 0.97× | — | ||
| Q3 25 | 1.69× | 6.89× | ||
| Q2 25 | 1.88× | — | ||
| Q1 25 | 2.24× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.66× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 1.91× | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KEYS
| Transferred At Point In Time | $790.0M | 56% |
| Electronicindustrial | $429.0M | 30% |
| Transferred Over Time | $200.0M | 14% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
